Information Journal Paper
APA:
Copy. (2018). Canagliflozin for the treatment of type 2 diabetes: a comparison between Japanese and non-Japanese patients. EXPERT OPINION ON PHARMACOTHERAPY, 19(-), 895-908. SID. https://sid.ir/paper/692154/en
Vancouver:
Copy. Canagliflozin for the treatment of type 2 diabetes: a comparison between Japanese and non-Japanese patients. EXPERT OPINION ON PHARMACOTHERAPY[Internet]. 2018;19(-):895-908. Available from: https://sid.ir/paper/692154/en
IEEE:
Copy, “Canagliflozin for the treatment of type 2 diabetes: a comparison between Japanese and non-Japanese patients,” EXPERT OPINION ON PHARMACOTHERAPY, vol. 19, no. -, pp. 895–908, 2018, [Online]. Available: https://sid.ir/paper/692154/en